# Ainnocence

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ainnocence

- Industry: Pharmaceuticals
- Headquarters: Shanghai, China
- Latest round: Angel (Nov 2, 2021)
- Investors on record: 1

## About

Established in 2021 and based in Shanghai, China, Ainnocence is a biopharmaceutical company that engaged in technical challenges in biopharmaceuticals. Dr. Lurong Pan, the founder and CEO, received his PhD from the University of Alabama at Birmingham and was head of Artificial Intelligence Department of Global Health Drug Research and Development Center (GHDDI).

The company focuses on the seamless integration of artificial intelligence and experimental technology. The company provides acomputing platform with tens of billions of virtual screening capabilities in various molecular forms for target mechanism analysis, precise drug molecular design and whole-process optimization of R&D strategies. The company also have early research and development capabilities for small molecules and biological drugs.

Following the funding in 2021, the company plans to use the investment to to deepen platform technology, promote pipeline projects, and expand the talent team.

## Funding rounds

- Angel, Nov 2, 2021 — Genesis Capital

## Investors

- Genesis Capital — Angel